Beijing Tiantan Hospital: Ischemia trials

The registry lists 28 Ischemia studies with Beijing Tiantan Hospital as lead sponsor. 9 are open to participants now and 0 have results posted.

Phase 2 11Phase 3 9Phase 4 1No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Effect of Acetaminophen on Neurological Outcome in Acute Ischemic Stroke Patients Undergoing Endovascular TreatmentNot yet recruitingNCT06767969Not applicable
• The Androtriol Injection for the Treatment of Acute Ischemic StrokeNot yet recruitingNCT06679322Phase 2
• GD-11 for Injection in the Treatment of Acute Ischemic StrokeRecruitingNCT06299579Phase 3
• Oxygen Concentration Target in Stroke Endovascular TreatmentRecruitingNCT06224426Not applicable
• EFfects of Y-6 SUblingual Tablets foR PaTients With AcUte Ischemic StRokE (FUTURE)Not yet recruitingNCT06138834Phase 2
• A Registry Study of Microcirculation Disorder After Cerebral Small Vessel Disease and Ischemic StrokeNot yet recruitingNCT06077305
• Cilostazol Dexborneol Versus Placebo for Microcirculation Dysfunction After Reperfusion Therapy in Patients With Acute Ischemic Stroke With Large Vessel OcclusionRecruitingNCT05836766Phase 2
• Efficacy and Safety of Sarecycline in Patients With Acute Ischemic Stroke After Reperfusion TherapyRecruitingNCT05836753Phase 2
• Cerebral Autoregulation Guiding Blood Pressure Management After RevascularizationNot yet recruitingNCT05670028Phase 2
• Y-3 Injection in the Treatment of Acute Ischemic Stroke Phase II Clinical TrialCompletedNCT06429384Phase 2
• Efficacy and Safety of Minocycline in Patients With Moderate to Severe Acute Ischemic StrokeCompletedNCT05836740Phase 3
• Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ）Status unknownNCT05745259Phase 3
• Tenecteplase REperfusion in Acute Ischemic sTroke Registry（TREAT）Status unknownNCT05724342
• Dengzhanxixin Injection for Acute Ischemic Stroke Receiving Reperfusion TherapyStatus unknownNCT05700097Phase 2
• Colchicine in High-risk Patients With Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3)CompletedNCT05439356Phase 3
• Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-II）Status unknownNCT05281549Phase 2
• Treatment of Acute Ischemic STroke With Edaravone Dexborneol II (TASTE-2)CompletedNCT05249920Phase 3
• Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-IIICompletedNCT05141305Phase 3
• Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-ⅡCompletedNCT04797013Phase 3
• Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events(TRACE)CompletedNCT04676659Phase 2
• The Effectiveness of Rehabilitation Training Based on Brain-computer Interface Technology to Improve the Upper Limb Motor Function of Ischemic Stroke.CompletedNCT04387474Not applicable
• Effects of Remote Ischemic Pre-Conditioning in Moyamoya Disease PatientsSuspendedNCT04064658Not applicable
• INdobufen Versus aSpirin in acUte Ischemic stRokE,INSURECompletedNCT03871517Phase 4
• Efficacy and Safety of Butylphthalide for Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis or Endovascular TreatmentCompletedNCT03539445Phase 3
• The Clinical Benefit and Risk of Oral Aspirin for Unruptured Intracranial Aneurysm Combined With Cerebral IschemiaStatus unknownNCT02846259
• A Safety and Effective Study of Ginkgolides Diterpene Lactone Meglumine Injection in the Treatment of Ischemic Stroke.CompletedNCT02526225Phase 2
• Platelet Reactivity in Acute Non-disabling Cerebrovascular EventsCompletedNCT02506140Phase 2/3
• Intervention to Bridge the Evidence-based Gap in Stroke Care QualityCompletedNCT02212912Not applicable